What is William Blair's Estimate for Trupanion Q2 Earnings?

Trupanion, Inc. (NASDAQ:TRUP - Free Report) - Analysts at William Blair raised their Q2 2025 earnings per share (EPS) estimates for Trupanion in a research note issued to investors on Wednesday, October 30th. William Blair analyst B. Vazquez now forecasts that the financial services provider will post earnings per share of $0.01 for the quarter, up from their prior estimate of ($0.01). William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Trupanion's current full-year earnings is ($0.34) per share. William Blair also issued estimates for Trupanion's Q3 2025 earnings at $0.03 EPS, Q4 2025 earnings at $0.11 EPS, Q3 2026 earnings at $0.02 EPS and FY2026 earnings at $0.13 EPS.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.42%. The firm had revenue of $327.50 million during the quarter, compared to analysts' expectations of $321.79 million. During the same quarter last year, the company posted ($0.10) EPS. The company's quarterly revenue was up 14.6% compared to the same quarter last year.

Several other research firms have also recently commented on TRUP. Evercore ISI raised Trupanion to a "strong-buy" rating in a research note on Friday, August 9th. Northland Securities lifted their price objective on Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a research report on Thursday. Stifel Nicolaus boosted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a report on Monday, September 23rd. Piper Sandler raised their target price on shares of Trupanion from $45.00 to $57.00 and gave the company a "neutral" rating in a research note on Thursday. Finally, Bank of America boosted their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a research note on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $44.67.

Trupanion Price Performance

Shares of Trupanion stock traded down $0.22 during midday trading on Friday, reaching $54.56. The company had a trading volume of 708,745 shares, compared to its average volume of 681,027. The stock has a fifty day simple moving average of $46.92 and a 200 day simple moving average of $36.00. Trupanion has a 1-year low of $19.69 and a 1-year high of $57.90. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of -170.50 and a beta of 1.73.

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 624 shares of the business's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Fawwad Qureshi sold 624 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the business's stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares of the company's stock, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,764 shares of company stock worth $405,238 in the last ninety days. Company insiders own 5.50% of the company's stock.

Institutional Trading of Trupanion

Several hedge funds have recently bought and sold shares of the stock. Hanseatic Management Services Inc. acquired a new position in shares of Trupanion in the third quarter valued at approximately $538,000. Fernwood Investment Management LLC boosted its stake in Trupanion by 33.3% in the 3rd quarter. Fernwood Investment Management LLC now owns 20,000 shares of the financial services provider's stock worth $840,000 after purchasing an additional 5,000 shares during the period. OmniStar Financial Group Inc. bought a new position in Trupanion during the 3rd quarter worth about $535,000. GAMMA Investing LLC raised its stake in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock valued at $61,000 after purchasing an additional 596 shares during the period. Finally, Handelsbanken Fonder AB bought a new stake in shares of Trupanion in the third quarter valued at about $248,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.